243 related articles for article (PubMed ID: 22563456)
21. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
22. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
Lim XF; Jia Q; Khong WX; Yan B; Premanand B; Alonso S; Chow VT; Kwang J
PLoS One; 2012; 7(1):e29751. PubMed ID: 22279543
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.
Ibba R; Carta A; Madeddu S; Caria P; Serreli G; Piras S; Sestito S; Loddo R; Sanna G
Viruses; 2021 Jan; 13(1):. PubMed ID: 33406781
[TBL] [Abstract][Full Text] [Related]
25. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
Huang SW; Tai CH; Fonville JM; Lin CH; Wang SM; Liu CC; Su IJ; Smith DJ; Wang JR
J Virol; 2015 Nov; 89(22):11500-6. PubMed ID: 26339057
[TBL] [Abstract][Full Text] [Related]
26. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
[TBL] [Abstract][Full Text] [Related]
27. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
28. Effects and mechanism of Aβ
Zhong M; Wang H; Yan H; Wu S; Wang K; Yang L; Cui B; Wu M; Li Y
Virol J; 2022 Sep; 19(1):151. PubMed ID: 36127711
[TBL] [Abstract][Full Text] [Related]
29. Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening.
Zhang QY; Li JQ; Li Q; Zhang Y; Zhang ZR; Li XD; Zhang HQ; Deng CL; Yang FX; Xu Y; Zhang B
Virol Sin; 2024 Apr; 39(2):301-308. PubMed ID: 38452856
[TBL] [Abstract][Full Text] [Related]
30. Validating Enterovirus D68-2A
Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates.
Wang Y; Wang H; Jiang X; Jiang Z; Guo T; Ji X; Li Y; Li Y; Li Z
Molecules; 2019 Mar; 24(5):. PubMed ID: 30862068
[TBL] [Abstract][Full Text] [Related]
32. Novel substituted heteroaromatic piperazine and piperidine derivatives as inhibitors of human enterovirus 71 and coxsackievirus a16.
Zhang X; Wang H; Li Y; Cao R; Zhong W; Zheng Z; Wang G; Xiao J; Li S
Molecules; 2013 Apr; 18(5):5059-71. PubMed ID: 23629759
[TBL] [Abstract][Full Text] [Related]
33. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
34. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
35. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
[TBL] [Abstract][Full Text] [Related]
36. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Enterovirus D68 Replication in Neuroblastoma Cells Is Associated with a Cell Culture-Adaptive Amino Acid Substitution in VP1.
Sooksawasdi Na Ayudhya S; Meijer A; Bauer L; Oude Munnink B; Embregts C; Leijten L; Siegers JY; Laksono BM; van Kuppeveld F; Kuiken T; Geurts-van Kessel C; van Riel D
mSphere; 2020 Nov; 5(6):. PubMed ID: 33148825
[TBL] [Abstract][Full Text] [Related]
38. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study.
Lin WY; Yu YJ; Jinn TR
Virol J; 2019 Jul; 16(1):94. PubMed ID: 31366366
[TBL] [Abstract][Full Text] [Related]
40. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
J Virol; 2019 May; 93(10):. PubMed ID: 30867299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
